Visit the News Hub Targeted therapy shrank tumors, shows promise in improving survival Huy Mach The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial.

Micropatterned nickel titanium (commonly known as nitinol) thin films with complex designs, high structural resolution and excellent biocompatibility can be cheaply fabricated using magnetron sputtering. Here, we show that these benefits can be leveraged to fabricate micromesh implants that are loaded with tumour-specific human chimeric antigen receptor (CAR)-T cells for the treatment of solid tumours.

Stanford researchers made a groundbreaking discovery about brain tumors. The study reports high-grade gliomas form synapses which hijack electrical signals from healthy neurons in the brain, promoting tumor growth. Interrupting the signals with a drug currently used to treat epilepsy reduces the tumor growth in mouse models.